Format

Send to

Choose Destination
J Med Chem. 2010 Sep 23;53(18):6720-9. doi: 10.1021/jm100839w.

Potent and fully noncompetitive peptidomimetic inhibitor of multidrug resistance P-glycoprotein.

Author information

1
Laboratoire des Protéines de Résistance aux Agents Chimiothérapeutiques, Equipe Labellisée Ligue 2009, Institut de Biologie et Chimie des Protéines, UMR 5086 CNRS, Université Lyon 1, IFR 128 BioSciences Gerland Lyon-Sud, F-69367 Lyon, France.

Abstract

N(α)-Boc-l-Asp(OBn)-l-Lys(Z)-OtBu (reversin 121, 1), an inhibitor of the P-gp ABC transporter, was used to conceive compounds inhibiting the drug efflux occurring through the Hoechst 33342 and daunorubicin transport sites of P-gp, respectively H and R sites. Replacement of the aspartyl residue by trans-4-hydroxy-l-proline (4(R)Hyp) gave compounds 11 and 15 characterized by half-maximal inhibitory concentrations (IC(50)) of 0.6 and 0.2 μM, which are 2- and 7-fold lower than that of the parent molecule. The difference in IC(50) between 11 and 15 rests on the carbonyl group of the peptidyl bond, reduced in 15. Those compounds are rather specific of P-gp, having no or limited activity on MRP1 and BCRP. 15 displayed no marked cytotoxicity up to 10-fold its IC(50). Importantly, 15 equally inhibited the Hoechst 33342 and daunorubicin effluxes through a typical noncompetitive inhibition mechanism, suggesting its binding to a site different from the H and R drug-transport sites.

PMID:
20731360
DOI:
10.1021/jm100839w
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center